WST•benzinga•
Keybanc Maintains Overweight on West Pharmaceutical Servs, Lowers Price Target to $400
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2022 by benzinga